Rad AI is the leader in generative AI solutions for radiology, transforming how radiologists work and improving patient care. Founded to harness AI for more efficient and accurate medical imaging, the company develops cutting-edge technology to streamline radiology workflows. Its flagship products, Rad AI Reporting and Rad AI Impressions, enhance reporting efficiency and have widespread adoption among U.S. radiologists. Rad AI Continuity further strengthens patient care by ensuring follow-ups for potential new cancers. With a strong track record of innovation and industry impact, Rad AI continues to shape the future of AI-driven healthcare solutions.
Rad AI has raised $60 million in a Series C funding round, valuing the company at $525 million. Transformation Capital led the new round, which included existing investors Khosla Ventures, World Innovation Lab, UP2398, Kickstart Fund, OCV Partners, Cone Health, and others. In total, Rad AI has raised $140 million to date.
Rad AI, San Francisco, California, United States, was founded in 2018 by Doktor Gurson and Jeff Chang. Rad AI operates primarily in North America, providing its generative AI solutions for radiology to thousands of radiologists across the U.S. and Canada. Recognized by CB Insights and AuntMinnie, Rad AI was named the 19th fastest-growing company in North America on the Deloitte Fast 500 in November 2024. "At Rad AI, we focus on empowering physicians with AI – saving physicians time, reducing burnout and improving the quality of patient care. Over the past few years, Rad AI has become a mission-critical part of physician and health system workflows across North America. This strategic funding round will accelerate our progress as the leading AI-driven workflow platform in healthcare," said Doktor Gurson, co-founder and CEO at Rad AI.
Share this post